ArticlemedRxiv : the preprint server for health sciences2026
The MHCII Immune Activation Score predicts risk of recurrence and benefit of taxanes in Basallike and HER2-enriched breast cancer.
Philip S Bernard et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.